Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
57
天
SERENA-6 interpretation and clinical implications: intercepting endocrine resistance in metastatic breast cancer
作者
François-Clement Bidard; Carlos Barrios; Giampaolo Bianchini; Adam M. Brufsky; Stephen Chia; Javier Cortes; Massimo Cristofanilli; Giuseppe Curigliano; Shaheenah Dawood; Peter A. Fasching; Lorenzo Gerratana; Antonio Giordano; Michail Ignatiadis; Hiroji Iwata; Wolfgang Janni; Elgene Lim; Kevin Kalinsky; Cynthia X. Ma; Erica L. Mayer; Arielle J. Medford; Jason A. Mouabbi; Joyce O’Shaughnessy; Yeon Hee Park; Javier Pascual; Pedram Razavi; Sarah Sammons; José Luis Sandoval; Luisana Sisca; Paolo Tarantino; Seth A. Wander; Gustavo Werutsky; Nicholas A. Turner展开收起
作者单位
1. Department of Medical Oncology, Inserm CIC 2501, Institut Curie, Paris, France; 2. UVSQ, Universite Paris-Saclay, Paris, France; 3. Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil; 4. Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy; 5. School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy; 6. UPMC Magee-Womens Hospital, Pittsburgh, USA; 7. Division of Malignant Hematology/Medical Oncology, Department of Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, USA; 8. BC Cancer – Vancouver Cancer Centre, Vancouver, Canada; 9. International Breast Cancer Center (IBCC), Pangaea Oncology, Quirón Group, Barcelona, Spain; 10. IOB Madrid, Institute of Oncology, Hospital Beata María Ana, Madrid, Spain; 11. Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain; 12. Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, Ridgewood, USA; 13. Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, USA; 14. Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy; 15. Istituto Europeo di Oncologia, IRCCS, Milano, Italy; 16. Mediclinic Hospital, Dubai, United Arab Emirates; 17. Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates; 18. Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany; 19. Department of Medical Oncology, CRO di Aviano, National Cancer Institute, IRCCS, Aviano, Italy; 20. Department of Medicine, University of Udine, Udine, Italy; 21. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; 22. Harvard Medical School, Boston, USA; 23. Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B.), Université libre de Bruxelles (ULB), Brussels, Belgium; 24. Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan; 25. Department of Obstetrics and Gynecology, University Hospital Ulm, Ulm, Germany; 26. Garvan Institute of Medical Research, Darlinghurst, Australia; 27. Faculty of Medicine, St Vincent’s Clinical School, UNSW Sydney, Darlinghurst, Australia; 28. St Vincent’s Hospital, Darlinghurst, Australia; 29. Department of Hematology and Oncology, Winship Cancer Institute of Emory University, Atlanta, USA; 30. Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, USA; 31. Mass General Cancer Center, Boston, USA; 32. Division of Cancer Medicine, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; 33. Baylor University Medical Center, Dallas, USA; 34. Texas Oncology, Dallas, USA; 35. Sarah Cannon Research Institute, Dallas, USA; 36. Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; 37. Medical Oncology Department, Hospital Universitario Virgen de la Victoria, Malaga, Spain; 38. GEICAM Spanish Breast Cancer Group, Madrid, Spain; 39. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA; 40. Translational Oncology Partnership Program, Memorial Sloan Kettering Cancer Center, New York, USA; 41. Dana-Farber Brigham Cancer Center, Boston, USA; 42. Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; 43. Dana-Farber Cancer Institute, Boston, USA; 44. Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland; 45. Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy; 46. Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy; 47. Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, USA; 48. Department of Medical Oncology, Mass General Brigham Cancer Institute, Harvard Medical School, Boston, USA; 49. Royal Marsden NHS Foundation Trust, London, UK展开收起
82
天
The clinical relevance of apocrine morphology in breast cancer depends on the estrogen receptor status
作者
Kei Kawashima; Masanori Oshi; Akimitsu Yamada; Kazutaka Narui; Zunairah Shah; Thaer Khoury; Itaru Endo; Kazuaki Takabe展开收起
作者单位
1. Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, USA; 2. Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan; 3. Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan; 4. Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, USA; 5. Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, USA; 6. Department of Surgery, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, the State University of New York, Buffalo, USA; 7. Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; 8. Department of Breast Surgery and Oncology, Tokyo Medical University, Tokyo, Japan; 9. Department of Breast Surgery, Fukushima Medical University, Fukushima, Japan展开收起
126
天
Targeted axillary dissection in breast cancer patients: a systematic review and meta-analysis
作者
Mohammed. N. Abdelaziz; Sagad O. O. Mohamed; Mohammed Hesham Nagi; Ibrahim Saleh Alawadi; Youstina Mohsen; Sohaila Essam Ibrahim; Radwa M. Abdelsattar; Asmaa. N. Abdelaziz; Mohamed Yasser; Sherif Wael; Hend A. Abdelgawad; Magdy Shehab; Khaled M. Abdelwahab; Omar Hamdy展开收起
作者单位
1. Faculty of Medicine, Mansoura University Hospital, Mansoura, Egypt; 2. University of Khartoum, Khartoum, Sudan; 3. Faculty of medicine, Kasr Alainy, Cairo University, Cairo, Egypt; 4. Surgical Oncology Department, Oncology Centre, Mansoura University, Mansoura, Egypt展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天